Vitality Women Prenatal
Natural health product licensed in Canada
If this product were sold in France
- Dose déclarée au-delà d'une limite
Cuivre: up to 3,000 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2,000 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 105 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 5 mg | 10,000 µg |
| Folate Source : Folate | 500 mcg | Not calculated |
| Acide pantothénique Source : D-Pantothénate de calcium | 10 mg | 20,000 µg |
| Cuivre Source : Sulfate de cuivre (II) | 1.5 mg | 3,000 µg |
| Fer Source : Sulfate ferreux | 4.5 mg | 9,000 µg |
| Biotine Source : Biotine | 150 mcg | 300 µg |
| Zinc Source : Sulfate de zinc | 7.5 mg | 15,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5 mg | 10,000 µg |
| Bêta-carotène Source : Bêta carotène Potency : 1,500 UI | 900 mcg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 8 mcg | 16 µg |
| Vitamine C Source : Acide ascorbique | 75 mg | 150,000 µg |
| Vitamine E Source : D-alpha-tocophéryl succinate Potency : 15 UI | 10 mg AT | Not calculated |
| Niacinamide Source : Niacinamide | 37.5 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 112.5 mg | 225,000 µg |
| Magnésium Source : Citrate de magnésium | 112.5 mg | 225,000 µg |
| Magnésium Source : Sulfate de magnésium | 112.5 mg | 225,000 µg |
| Magnésium Source : Lactate de magnésium | 112.5 mg | 225,000 µg |
| Sélénium Source : Sélénite de sodium | 52.5 mcg | 105 µg |
| Boron Source : Acide borique | 75 mcg | Not calculated |
Non-medicinal ingredients
phosphate de dicalcium, Cire de Carnauba, Cross-linked cellulose gum, Hydroxyde de sodium, Gum acacia, Acide L-aspartique, Hydroxypropylméthylcellulose, Poly(éthylène glycol), Maltodextrine, Eau, Inuline, Microcrystalline cellulose, Natural Vanillin, Stéarate de magnésium, Acide stéarique, citrate de sodium, Citrate de potassium, Hydroxypropylcellulose, Glycine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the risk of neural tube defects when taking daily prior to becoming pregnant and during early pregnancy. Helps the body to metabolize carbohydrates, fats and proteins. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- Melaleuca, Inc.
- NPN or DIN-HM
- 80021291
- Status
- Active licence
- Licence date
- 20 August 2010
- Revision date
- 13 April 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80021291
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vitality Women Prenatal (Melaleuca, Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80021291-vitality-women-prenatal, updated 13 April 2021.